These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22369089)

  • 1. Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.
    Kamugisha E; Jing S; Minde M; Kataraihya J; Kongola G; Kironde F; Swedberg G
    Malar J; 2012 Feb; 11():58. PubMed ID: 22369089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?
    Kamugisha E; Bujila I; Lahdo M; Pello-Esso S; Minde M; Kongola G; Naiwumbwe H; Kiwuwa S; Kaddumukasa M; Kironde F; Swedberg G
    Acta Trop; 2012 Feb; 121(2):148-51. PubMed ID: 22118982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.
    Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S
    Malar J; 2012 Dec; 11():434. PubMed ID: 23272998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
    Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
    Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
    Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD
    Malar J; 2009 May; 8():107. PubMed ID: 19454000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
    Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
    J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
    Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK
    Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
    Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A
    Malar J; 2013 Mar; 12():103. PubMed ID: 23506218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.
    Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Mårtensson A
    Malar J; 2011 Mar; 10():64. PubMed ID: 21410954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
    Spalding MD; Eyase FL; Akala HM; Bedno SA; Prigge ST; Coldren RL; Moss WJ; Waters NC
    Malar J; 2010 Nov; 9():338. PubMed ID: 21106088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
    Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB
    Malar J; 2007 Jul; 6():92. PubMed ID: 17631681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana.
    Eibach D; Ceron N; Krishnalall K; Carter K; Bonnot G; Bienvenu AL; Picot S
    Malar J; 2012 Oct; 11():347. PubMed ID: 23083017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of
    Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
    Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Björkman A; Mårtensson A
    Clin Infect Dis; 2011 Apr; 52(7):873-82. PubMed ID: 21427394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.
    Ishengoma DS; Mandara CI; Francis F; Talundzic E; Lucchi NW; Ngasala B; Kabanywanyi AM; Mahende MK; Kamugisha E; Kavishe RA; Muro F; Mohamed A; Mandike R; Mkude S; Chacky F; Paxton L; Greer G; Kitojo CA; Njau R; Martin T; Venkatesan M; Warsame M; Halsey ES; Udhayakumar V
    Malar J; 2019 Mar; 18(1):88. PubMed ID: 30898164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.
    Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group
    Lancet Infect Dis; 2015 Jun; 15(6):692-702. PubMed ID: 25788162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos.
    Mayxay M; Khanthavong M; Chanthongthip O; Imwong M; Pongvongsa T; Hongvanthong B; Phompida S; Vanisaveth V; White NJ; Newton PN
    Malar J; 2012 Jun; 11():184. PubMed ID: 22681769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.